Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Libert

Showing results (41-50 of 245) with videos related to

Pageof 25
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|September 29, 2011
X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of femalesIris Pinheiro, Lien Dejager, Claude Libert
EMBO Molecular Medicine|June 8, 2026
Metabolism meets immunity: TCA-cycle activation protects the vulnerable newbornTineke Vanderhaeghen, Claude Libert, Jolien Vandewalle
Current Opinion in Pharmacology|January 29, 2020
Potential of glucocorticoids to treat intestinal inflammation during sepsisKelly Van Looveren, Charlotte Wallaeys, Claude Libert
Drug Discovery Today|May 17, 2015
Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disordersDelphine Demeestere, Claude Libert, Roosmarijn E Vandenbroucke
Drug Discovery Today|July 13, 2011
Matrix metalloproteinases as drug targets in ischemia/reperfusion injuryEline Dejonckheere, Roosmarijn E Vandenbroucke, Claude Libert
International Journal of Molecular Sciences|May 13, 2018
A New Venue of TNF TargetingSophie Steeland, Claude Libert, Roosmarijn E Vandenbroucke
EMBO Molecular Medicine|July 7, 2018
Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?Lise Van Wyngene, Jolien Vandewalle, Claude Libert
Trends in Endocrinology and Metabolism: TEM|May 6, 2025
Balancing metabolism and regeneration in liver diseases through HNF4α targetingCéline Van Dender, Jolien Vandewalle, Claude Libert
Drug Discovery Today|April 16, 2016
Nanobodies as therapeutics: big opportunities for small antibodiesSophie Steeland, Roosmarijn E Vandenbroucke, Claude Libert
EMBO Molecular Medicine|December 27, 2022
Paneth cells as the cornerstones of intestinal and organismal health: a primerCharlotte Wallaeys, Natalia Garcia-Gonzalez, Claude Libert
Pageof 25

Showing results (41-50 of 245) with videos related to

Sort By:
Pageof 25
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|September 29, 2011
X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of femalesIris Pinheiro, Lien Dejager, Claude Libert
EMBO Molecular Medicine|June 8, 2026
Metabolism meets immunity: TCA-cycle activation protects the vulnerable newbornTineke Vanderhaeghen, Claude Libert, Jolien Vandewalle
Current Opinion in Pharmacology|January 29, 2020
Potential of glucocorticoids to treat intestinal inflammation during sepsisKelly Van Looveren, Charlotte Wallaeys, Claude Libert
Drug Discovery Today|May 17, 2015
Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disordersDelphine Demeestere, Claude Libert, Roosmarijn E Vandenbroucke
Drug Discovery Today|July 13, 2011
Matrix metalloproteinases as drug targets in ischemia/reperfusion injuryEline Dejonckheere, Roosmarijn E Vandenbroucke, Claude Libert
International Journal of Molecular Sciences|May 13, 2018
A New Venue of TNF TargetingSophie Steeland, Claude Libert, Roosmarijn E Vandenbroucke
EMBO Molecular Medicine|July 7, 2018
Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?Lise Van Wyngene, Jolien Vandewalle, Claude Libert
Trends in Endocrinology and Metabolism: TEM|May 6, 2025
Balancing metabolism and regeneration in liver diseases through HNF4α targetingCéline Van Dender, Jolien Vandewalle, Claude Libert
Drug Discovery Today|April 16, 2016
Nanobodies as therapeutics: big opportunities for small antibodiesSophie Steeland, Roosmarijn E Vandenbroucke, Claude Libert
EMBO Molecular Medicine|December 27, 2022
Paneth cells as the cornerstones of intestinal and organismal health: a primerCharlotte Wallaeys, Natalia Garcia-Gonzalez, Claude Libert
Pageof 25